ARTICLE | Company News
Invitrogen, Prodesse deal
July 31, 2006 7:00 AM UTC
IVGN granted Prodesse a nonexclusive worldwide license to use its LUX (light upon extension) technology to develop diagnostic assays for infectious diseases. IVGN is eligible for milestones and royalt...